글로벌 고혈압 관리 장비 시장 – 2029년까지의 산업 동향 및 예측

고혈압 관리 장비 시장 의 시장 분석 및 통찰력

Data Bridge Market Research에 따르면 고혈압 관리 장치 시장은 2022~2029년 예측 기간 동안 7.27%의 CAGR로 성장하여 2029년까지 95억 달러 규모에 이를 것으로 예측됩니다.

고혈압 관리 장치는 현재 주요 시장 참여자들이 개발 및 임상 시험을 진행 중인 의료 기기이지만, 여전히 많은 변형이 존재합니다. 이러한 의료 기기는 효과적인 의약품이 부족하기 때문에 인간의 심혈관 질환과 장애를 매우 간단하고 경제적인 방식으로 관리하는 데 중점을 두고 개발되고 있습니다.

고혈압 관련 질환 을 앓고 있는 환자의 수가 증가 하고 이러한 환자의 임상적 요구가 충족되지 않은 것은 2022-2029년 예측 기간 동안 고혈압 관리 장치 시장 성장을 가속화하는 주요 요인입니다. 더욱이 효과적인 관리 요법이 부족한 것도 2022-2029년 예측 기간 동안 고혈압 관리 장치 시장 성장을 촉진할 것으로 예상됩니다. 그러나 보험 적용 범위가 부족하고 가격이 높기 때문에 2022-2029년 예측 기간 동안 고혈압 관리 장치 시장 성장이 제한될 것이고, 심장병 발병 위험이 높아지고 뇌졸중을 유발하는 의학적 상태는 2022-2029년 예측 기간 동안 시장 성장에 도전이 될 것입니다.

또한, 다양한 임상 시험을 통해 얻은 긍정적인 임상 데이터의 증가와 인지율 증가로 인해 위에 언급된 예측 기간 동안 고혈압 관리 장치 시장에 대한 충분한 기회가 창출될 것입니다.

This hypertension management devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on hypertension management devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Hypertension Management Devices Market Scope and Market Size

The hypertension management devices market is segmented on the basis of technology, product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of technology, the hypertension management devices market has been segmented into radiofrequency ablation, ultrasound, micro-infusion and others.
• Based on product, the hypertension management devices market has been segmented into renal denervation devices, carotid sinus stimulation devices and respiratory modulation devices.
• Hypertension management devices market has been segmented on the basis of application into hospitals, clinics and home care.

Hypertension Management Devices Market Country Level Analysis

The hypertension management devices market is analysed and market size insights and trends are provided by country, technology, product and application as referenced above.

The countries covered in the hypertension management devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the hypertension management devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to rise in prevalence of hypertension as well as resistant hypertension, presence of major players, and increase in adoption of advanced devices to monitor hypertension. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to increase in the geriatric population suffering with hypertension, rise in adoption of new treatment procedure to manage hypertension, surge in health care expenditure, and increase in awareness among people about preventive health care in this region.

The country section of the hypertension management devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The hypertension management devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hypertension management devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hypertension management devices market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Hypertension Management Devices Market Share Analysis

The hypertension management devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hypertension management devices market.

고혈압 관리 장치 시장 보고서에서 활동하는 주요 기업으로는 Pfizer Inc., Amgen Inc., Cytokinetics, Inc., Hikma Pharmaceutical PLC., AbbVie Inc., Lupin Ltd., Wockhardt, Glenmark., Zydus Pharmaceutical Inc., Amneal Pharmaceutical LLC., Accord Healthcare, Aurobindo Pharma, Abbott, Medtronic, BD, Cook, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd 등이 있습니다.  

SKU-50536